WSJ: Awash in Fake Drugs, Nigerians Fight Back

Today’s Wall Street Journal features Sproxil’s partnership with the National Agency for Food and Drug Administration and Control (Nigeria’s FDA) and one of Nigeria’s largest drug companies, BIOFEM Pharmaceuticals to deliver extra value to consumers in Nigeria in the fight against counterfeits.


This entry was posted in Press, Updates by ashifi. Bookmark the permalink.

About ashifi

Sproxil provide software and systems that capture market intelligence in emerging markets using cell phones. Our service provides automatic protection against counterfeiters.